Clinical epidemiology of hospitalized patients with coronavirus disease 2019 (COVID-19) in Japan: report of the COVID-19 registry Japan

…, A Mikami, W Sugiura… - Clinical Infectious …, 2021 - academic.oup.com
Background There is limited understanding of the characteristics of patients with coronavirus
disease 2019 (COVID-19) requiring hospitalization in Japan. Methods This study included …

Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G

…, F Wang, K Stewart-Maynard, W Sugiura… - Nucleic acids …, 2007 - academic.oup.com
APOBEC3G (A3G), a host protein that inhibits HIV-1 reverse transcription and replication in
the absence of Vif, displays cytidine deaminase and single-stranded (ss) nucleic acid …

Molecular cloning and characterization of the gene coding for azoreductase from Bacillus sp. OY1-2 isolated from soil

Y Suzuki, T Yoda, A Ruhul, W Sugiura - Journal of biological chemistry, 2001 - ASBMB
Azo dyes are regarded as pollutants because they are not readily reduced under aerobic
conditions. Bacillussp. OY1-2 transforms azo dyes into colorless compounds, and this …

Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration

…, K Ariyoshi, MB Bouzas, P Cahn, W Sugiura… - PLoS …, 2005 - journals.plos.org
Background The genetic differences among HIV-1 subtypes may be critical to clinical management
and drug resistance surveillance as antiretroviral treatment is expanded to regions of …

The APOBEC3C crystal structure and the interface for HIV-1 Vif binding

…, N Watanabe, A Suzuki, W Sugiura… - Nature structural & …, 2012 - nature.com
The human apolipoprotein B mRNA-editing enzyme catalytic polypeptide–like 3 (APOBEC3,
referred to as A3) proteins are cellular cytidine deaminases that potently restrict retrovirus …

Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence …

…, M Stanojevic, MA Stefani, W Sugiura… - PLoS …, 2015 - journals.plos.org
Background Regional and subtype-specific mutational patterns of HIV-1 transmitted drug
resistance (TDR) are essential for informing first-line antiretroviral (ARV) therapy guidelines …

Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan

…, Y Asai, N Matsunaga, S Kutsuna, W Sugiura… - BMJ open, 2021 - bmjopen.bmj.com
Objectives To investigate the risk factors contributing to severity on admission. Additionally,
risk factors of worst severity and fatality were studied. Moreover, factors were compared …

Correlates of neutralizing/SARS-CoV-2-S1-binding antibody response with adverse effects and immune kinetics in BNT162b2-vaccinated individuals

…, K Yoshimura, S Oka, A Mikami, W Sugiura… - Scientific Reports, 2021 - nature.com
While mRNA vaccines against SARS-CoV-2 are exceedingly effective in preventing
symptomatic infection, their immune response features remain to be clarified. In the present …

Sex‐associated differences between BMI and SARS‐CoV‐2 antibody titers following the BNT162b2 vaccine

…, N Inamura, M Konishi, M Ozeki, K Miyo, W Sugiura… - …, 2022 - Wiley Online Library
Objective This study investigated the sex‐associated difference in the impact of obesity on
antibody response to a COVID‐19 vaccine. Methods This study included 2,435 health care …

Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140

PL Earl, W Sugiura, DC Montefiori, CC Broder… - Journal of …, 2001 - Am Soc Microbiol
The biologically active form of the human immunodeficiency virus type 1 (HIV-1) envelope (Env)
glycoprotein is oligomeric. We previously described a soluble HIV-1 IIIB Env protein, …